Fem-Mono en es it fr

Fem-Mono Brand names, Fem-Mono Analogs

Fem-Mono Brand Names Mixture

  • No information avaliable

Fem-Mono Chemical_Formula


Fem-Mono RX_link


Fem-Mono fda sheet


Fem-Mono msds (material safety sheet)

Fem-Mono MSDS

Fem-Mono Synthesis Reference

Hayward et al., Can.J.Chem., 45; 2191-2192 (1967)

Fem-Mono Molecular Weight

191.139 g/mol

Fem-Mono Melting Point


Fem-Mono H2O Solubility

1.07E+005 mg/L

Fem-Mono State


Fem-Mono LogP


Fem-Mono Dosage Forms

Tablet (immediate release); Tablet (extended release)

Fem-Mono Indication

For the prevention of angina pectoris due to coronary artery disease and the treatment of acute and chronic angina pectoris, hypertension, and myocardial infarction.

Fem-Mono Pharmacology

Isosorbide-5-mononitrate, the long-acting metabolite of isosorbide dinitrate, is used as a vasodilatory agent in the management of angina pectoris. By dilating the vessels, it lowers the blood pressure and reduces the left ventricular preload and afterload, therefore, leads to a reduction of myocardial oxygen requirement.

Fem-Mono Absorption


Fem-Mono side effects and Toxicity

Symptoms of overdose include vasodilatation, venous pooling, reduced cardiac output, and hypotension. LD50=mg/kg(orally in rat)

Fem-Mono Patient Information

Fem-Mono Organisms Affected

Humans and other mammals